Phase
Condition
Breast Cancer
Cancer
Treatment
Usual Care
Multicomponent Adherence Intervention
Clinical Study ID
Ages 18-99 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Women or men age >18 years
Diagnosed with stage I-III breast cancer prescribed endocrine therapy
Within 3-years of the end of early active treatment (e.g., surgery, chemotherapy notincluding human epidermal growth factor receptor 2 (HER2)-directed therapy,radiation)
Patients must be prescribed at least 1 antihypertensive or statin medication for CVDprevention
Self-report of at least some nonadherence ET or CVD medication on DOSE-NonadherenceExtent of Nonadherence questionnaire
Exclusion
Exclusion Criteria:
Evidence of breast cancer recurrence
Non-English or Non-Spanish speaking
Not cognitively able to complete study requirements
Do not follow with either a primary care provider or cardiologist within the NewYork Presbyterian Health system's Epic EHR
Inability to provide informed consent
Study Design
Connect with a study center
Columbia University Medical Center
New York, New York 10032
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.